Monogram Technologies agrees to be acquired by Zimmer Biomet for $4.04 per share plus contingent value rights

Monogram Technologies Inc.

Stockholders receive $4.04 cash per share and one CVR under the merger agreement signed July 11, 2025.
CVRs offer potential milestone payments of up to $1.04, $1.08, $3.41, $3.41, and $3.43 per CVR through 2030.
Zimmer Biomet provides a $15 million delayed draw loan to Monogram if merger closes after December 2025.
Monogram must pay an $11 million termination fee under certain conditions if the deal fails to close.
Voting agreement with certain stockholders commits them to approve the merger and oppose competing proposals.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.